The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Yahoo Finance discussed the stock recently as it posted AbbVie Reports Full-Year and Fourth-Quarter 2023 Financial Results.
Abbvie Inc is listed on the NYSE as a member of the Healthcare sector and is a part of the Drug Manufacturers – General industry. At the end of the last regular session, the stock closed at $168.67 and fluctuated between $172.85 as its day high and $165.23 as its day low. The current market capitalization of Abbvie Inc is $297.79B. A total of 7.87 million shares were traded on the day, compared to an average of 5.40M shares.
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, ABBV has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 64 BUYs and 49 SELLs from insiders. Insiders purchased 936,824 shares during that period but sold 771,700.
In the most recent transaction, Donoghoe Nicholas sold 2,912 shares of ABBV for 154.72 per share on Dec 26. After the transaction, the EVP, CHIEF BUS/STRAT OFFICER now owns 55,903 company shares. In a previous transaction on Aug 01, GONZALEZ RICHARD A sold 60,000 shares at 148.58 per share. ABBV shares that CHAIRMAN OF THE BOARD AND CEO owns now total 565,294.
Among the insiders who sold shares, GONZALEZ RICHARD A disposed of 18,500 shares on Jul 31 at a per-share price of $149.15. This resulted in the CHAIRMAN OF THE BOARD AND CEO holding 625,294 shares of ABBV after the transaction. In another insider transaction, Sorg Elaine K. sold 6,130 shares at $165.00 per share on Apr 25. Company shares held by the SVP, US COMMERCIAL OPERATIONS now total 35,330.
It is more appealing for investors to invest in companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook for the company. Abbvie Inc pays an annual dividend of $6.23, resulting in a dividend yield of 3.69%, and it has a price to earnings (P/E) ratio of 61.86. ABBV’s most recent ex-dividend date was 1/12/2024 when it declared a $1.55 quarterly dividend that was paid in cash on 2/15/2024. Previously, the company paid the dividend on 11/15/2023 with an ex-dividend date of 10/12/2023. The ABBV stock dividend was $1.48 per share in cash.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for ABBV in the last 3 months, the mean price target is $173.21 with high estimates of $205.00 and low estimates of $135.00. In terms of 52-week highs and lows, ABBV has a high of $167.95 and a low of $130.96.
As of this writing, ABBV has an earnings estimate of $Ambev S.A. per share for the current quarter. EPS was calculated based on a consensus of AbbVie Inc. estimates, with a high estimate of $Able View Global Inc. per share and a lower estimate of $ABBVIE INC ABBVIE ORD SHS.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ABBV’s latest balance sheet shows that the firm has $9.83B in Cash & Short Term Investments as of fiscal 2021. There were $76.68B in debt and $35.19B in liabilities at the time. Its Book Value Per Share was $6.85, while its Total Shareholder’s Equity was $15.44B.
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ABBV is Buy with a score of 4.16.